pharmaceutical sales and marketing

Latest Headlines

Latest Headlines

AZ: No more free trips for doctors

AstraZeneca CEO David Brennan (photo) announced at a conference in Istanbul that his company will no longer foot the bill for physician trips to international medical congresses."We have decided that

Vertex to field small, specialized sales force on Incivek

With all eyes on its bid to out-market Merck's new hepatitis C drug Victrelis, Vertex Pharmaceuticals says its targeted sales force is up to the job. In an interview with Dow Jones, Vertex chief

High court to weigh data-mining laws

The U.S. Supreme Court has decided to consider a case that could change the face of drug marketing. At issue is whether market research firms can collect prescription information and resell it to

Novartis, Sanofi debut first Android apps

Now that new Android gadgets hit the market about once a week, Big Pharma has decided to add its voice to that platform. Sanofi-Aventis ($SNY) and Novartis ($NVS) have both introduced new Android

GSK pitches Votrient rebate if trial favors Sutent

Drugmakers have held out plenty of different carrots to induce the U.K.'s cost-effectiveness watchdog to accept expensive meds for use on the National Health Service. Companies have offered paybacks

FDA won't deliver on social media rules

Once again, the FDA fails to meet a deadline. This time, it's the promised guidelines on using the Internet and social media for marketing--the guidelines that drugmakers have been anxiously

Pfizer lets reps race with e-sampling system

In the ongoing tussle between human and machine--in this case, pharma reps and online marketing--Pfizer ($PFE) has awarded new points to the machine. But as the Wall Street Journal Health Blog

Drug, device reps add iPads to tool belt

If Santa doesn't bring you an iPad this holiday season, then maybe your pharma employer will. Drug and device firms are arming their sales people with the tablet devices by the thousands, the Wall

Primary-care docs think GSK reps are tops

In the latest sales popularity contest, GlaxoSmithKline ($GSK) reps are the prom kings and queens of pharma marketing. According to the market research firm SDI's 2010 study, primary care doctors

Primary care docs want samples from reps

What do doctors really prefer: A live sales rep or a computer? According to a new survey, the human being wins--at least for primary care doctors collecting drug samples. Some 73 percent of